Results
Solara Q2 FY27 Revenue Up 33%, EBITDA Doubles to INR 769Mn
Solara Active Pharma Sciences reported Q2 FY27 financial results, its best quarter in five years, with revenue of INR 4,178 Mn, up 33% YoY.
Base business (ex-Ibuprofen) drove performance with revenue
